Janux Therapeutics, Inc.JANXNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank33
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Latest
-87.69%
↓ 12% vs avg
Percentile
P33
Within normal range
Streak
1 yr
Consecutive declineDecelerating
Average
-78.24%
Historical baseline
PeriodValue
2025-87.69%
202413.37%
2023-17.83%
2022-152.84%
2021-288.56%
2020-14.13%
20190.00%